TY - JOUR
T1 - Timing of Primary Surgery for Cleft Palate
AU - Gamble, Carrol
AU - Persson, Christina
AU - Willadsen, Elisabeth
AU - Albery, Liz
AU - Soegaard Andersen, Helene
AU - Zattoni Antoneli, Melissa
AU - Appelqvist, Malin
AU - Aukner, Ragnhild
AU - Bodling, Pia
AU - Bowden, Melanie
AU - Brunnegård, Karin
AU - Cairns, Gillian
AU - Calladine, Samantha
AU - Campbell, Linsay
AU - Clayton-Smith, Jill
AU - Cooper, Rachael
AU - Conroy, Elizabeth
AU - El-Angbawi, Ahmed
AU - Kildegaard Emborg, Berit
AU - Enfält Wikman, Josefin
AU - Fitzpatrick, Beth
AU - Fukushiro, Ana Paula
AU - Guedes de Azevedo Bento Gonçalves, Cristina
AU - Havstam, Christina
AU - Hvistendahl, Anne Katherine
AU - Jorgensen, Line Dahl
AU - Klinto, Kristina
AU - Berntsen Kvinnsland, Marit
AU - Larham, Catriona
AU - Lemvik, Jorunn
AU - Leturgie, Louise
AU - Liljerehn, Eva
AU - Lodge, Natalie
AU - Lohmander, Anette
AU - McMahon, Siobhan
AU - Mehendale, Felicity
AU - Miguel, Haline Coracine
AU - Moe, Marianne
AU - Nielsen, Joan Bogh
AU - Nyberg, Jill
AU - Pedersen, Nina-Helen
AU - Phippen, Ginette
AU - Alvarez Piazentin-Penna, Silvia Helena
AU - Patrick, Kathryn
AU - Pliskin, Lindsay
AU - Rigby, Lucy
AU - Semb, Gunvor
AU - Southby, Lucy
AU - Sporre, Maria
AU - Björkman Taleman, Ann-Sofie
AU - TOPS Study Group
N1 - Copyright © 2023 Massachusetts Medical Society.
PY - 2023/8/31
Y1 - 2023/8/31
N2 - BACKGROUND: Among infants with isolated cleft palate, whether primary surgery at 6 months of age is more beneficial than surgery at 12 months of age with respect to speech outcomes, hearing outcomes, dentofacial development, and safety is unknown.METHODS: We randomly assigned infants with nonsyndromic isolated cleft palate, in a 1:1 ratio, to undergo standardized primary surgery at 6 months of age (6-month group) or at 12 months of age (12-month group) for closure of the cleft. Standardized assessments of quality-checked video and audio recordings at 1, 3, and 5 years of age were performed independently by speech and language therapists who were unaware of the trial-group assignments. The primary outcome was velopharyngeal insufficiency at 5 years of age, defined as a velopharyngeal composite summary score of at least 4 (scores range from 0 to 6, with higher scores indicating greater severity). Secondary outcomes included speech development, postoperative complications, hearing sensitivity, dentofacial development, and growth.RESULTS: We randomly assigned 558 infants at 23 centers across Europe and South America to undergo surgery at 6 months of age (281 infants) or at 12 months of age (277 infants). Speech recordings from 235 infants (83.6%) in the 6-month group and 226 (81.6%) in the 12-month group were analyzable. Insufficient velopharyngeal function at 5 years of age was observed in 21 of 235 infants (8.9%) in the 6-month group as compared with 34 of 226 (15.0%) in the 12-month group (risk ratio, 0.59; 95% confidence interval, 0.36 to 0.99; P = 0.04). Postoperative complications were infrequent and similar in the 6-month and 12-month groups. Four serious adverse events were reported (three in the 6-month group and one in the 12-month group) and had resolved at follow-up.CONCLUSIONS: Medically fit infants who underwent primary surgery for isolated cleft palate in adequately resourced settings at 6 months of age were less likely to have velopharyngeal insufficiency at the age of 5 years than those who had surgery at 12 months of age. (Funded by the National Institute of Dental and Craniofacial Research; TOPS ClinicalTrials.gov number, NCT00993551.).
AB - BACKGROUND: Among infants with isolated cleft palate, whether primary surgery at 6 months of age is more beneficial than surgery at 12 months of age with respect to speech outcomes, hearing outcomes, dentofacial development, and safety is unknown.METHODS: We randomly assigned infants with nonsyndromic isolated cleft palate, in a 1:1 ratio, to undergo standardized primary surgery at 6 months of age (6-month group) or at 12 months of age (12-month group) for closure of the cleft. Standardized assessments of quality-checked video and audio recordings at 1, 3, and 5 years of age were performed independently by speech and language therapists who were unaware of the trial-group assignments. The primary outcome was velopharyngeal insufficiency at 5 years of age, defined as a velopharyngeal composite summary score of at least 4 (scores range from 0 to 6, with higher scores indicating greater severity). Secondary outcomes included speech development, postoperative complications, hearing sensitivity, dentofacial development, and growth.RESULTS: We randomly assigned 558 infants at 23 centers across Europe and South America to undergo surgery at 6 months of age (281 infants) or at 12 months of age (277 infants). Speech recordings from 235 infants (83.6%) in the 6-month group and 226 (81.6%) in the 12-month group were analyzable. Insufficient velopharyngeal function at 5 years of age was observed in 21 of 235 infants (8.9%) in the 6-month group as compared with 34 of 226 (15.0%) in the 12-month group (risk ratio, 0.59; 95% confidence interval, 0.36 to 0.99; P = 0.04). Postoperative complications were infrequent and similar in the 6-month and 12-month groups. Four serious adverse events were reported (three in the 6-month group and one in the 12-month group) and had resolved at follow-up.CONCLUSIONS: Medically fit infants who underwent primary surgery for isolated cleft palate in adequately resourced settings at 6 months of age were less likely to have velopharyngeal insufficiency at the age of 5 years than those who had surgery at 12 months of age. (Funded by the National Institute of Dental and Craniofacial Research; TOPS ClinicalTrials.gov number, NCT00993551.).
KW - Child, Preschool
KW - Humans
KW - Infant
KW - Allied Health Personnel
KW - Cleft Palate/complications
KW - Europe
KW - Postoperative Complications/epidemiology
KW - Velopharyngeal Insufficiency/diagnosis
KW - South America
KW - Diagnostic Techniques, Surgical
UR - http://www.scopus.com/inward/record.url?scp=85168929469&partnerID=8YFLogxK
U2 - 10.1056/NEJMoa2215162
DO - 10.1056/NEJMoa2215162
M3 - Journal article
C2 - 37646677
SN - 0028-4793
VL - 389
SP - 795
EP - 807
JO - The New England journal of medicine
JF - The New England journal of medicine
IS - 9
ER -